BeOne Medicines (ONC) EBT Margin Growth (5y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 692.00 |
| Dec 31, 2025 | 49,146.00 |
| Sep 30, 2025 | 48,807.00 |
| Jun 30, 2025 | 52,222.00 |
| Mar 31, 2025 | 69,990.00 |
| Dec 31, 2024 | 66,095.00 |
| Sep 30, 2024 | 61,219.00 |
| Jun 30, 2024 | 4,448.00 |
| Mar 31, 2024 | 18,288.00 |
| Dec 31, 2023 | 41,387.00 |
| Sep 30, 2023 | 29,680.00 |
| Jun 30, 2023 | 24,333.00 |
| Mar 31, 2023 | 25,824.00 |
| Dec 31, 2022 | 40,585.00 |
| Sep 30, 2022 | -19,408.00 |
| Jun 30, 2021 | 578,367.00 |
| Mar 31, 2021 | 325,349.00 |
| Dec 31, 2020 | -100,745.00 |
| Sep 30, 2020 | 53,677.00 |
| Jun 30, 2020 | -10,589.00 |
| Mar 31, 2020 | 4,251.00 |